Author:
Lyseng-Williamson Katherine A.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Adrucil® (fluorouracil injection, solution): US prescribing information. Irvine (CA): Teva Parenteral Medicines, Inc.; 2016.
2. Capecitabine tablet (film-coated): US prescribing information. North Wales (PA): Teva Pharmaceuticals USA Inc.; 2016.
3. Mikhail SE, Sun JF, Marshall JL. Safety of capecitabine: a review. Expert Opin Drug Saf. 2010;9:831–41.
4. Polk A, Vistisen K, Vaage-Nilsen M, et al. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol. 2014;15:47.
5. Polk A, Vaage-Nilsen M, Vistisen K, et al. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013;39(8):974–84.